Men with sub-threshold depression were significantly less likely to have PSA tests than men who were not depressed, suggesting that somatic symptoms associated with depression may be more pertinent during healthcare visits, or that GPs may be less likely to initiate discussions about PSA testing and prostate cancer with depressed men for fear of exacerbating their condition[31]. This evidence concerns the gene KLK3 and depressive symptom measurement.